Lugar de publicación
- SELECTIVE TASK-1 INHIBITOR WITH A DEFINED STRUCTURE-ACTIVITY RELATIONSHIP REDUCES CANCER CELL PROLIFERATION AND VIABILITY. 65(22):15014-15027. 2022
- TDP-43 MODULATION BY TAU-TUBULIN KINASE 1 INHIBITORS: A NEW AVENUE FOR FUTURE AMYOTROPHIC LATERAL SCLEROSIS THERAPY. 65(2):1585-1607. 2022
- FACTORS DETERMINING THE SUPERIOR PERFORMANCE OF LIPID/DNA/PROTAMMINE NANOPARTICLES OVER LIPOPLEXES. 54(12):4160-4171. 2011
- HISTORICAL AND CURRENT PERSPECTIVES OF NEUROACTIVE COMPOUNDS DERIVED FROM LATIN AMERICA. 6:997-1008. 2006